389 results on '"Selaru, Florin M"'
Search Results
2. A combination therapy of bortezomib, CXCR4 inhibitor, and checkpoint inhibitor is effective in cholangiocarcinoma in vivo
3. Adipokine C1q/Tumor Necrosis Factor- Related Protein 3 (CTRP3) Attenuates Intestinal Inflammation Via Sirtuin 1/NF-κB Signaling
4. Challenges in IBD Research 2024: Novel Technologies
5. Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
6. Prognostic Value of Lymph Node Ratio in Patients with Resected Synchronous Colorectal Liver Metastases and Less Than 12 Examined Lymph Nodes
7. Patient-derived functional organoids as a personalized approach for drug screening against hepatobiliary cancers
8. Untethered shape-changing devices in the gastrointestinal tract
9. PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease
10. A patient-like swine model of gastrointestinal fibrotic strictures for advancing therapeutics
11. Transitional changes in gastrointestinal transit and rectal sensitivity from active to recovery of inflammation in a rodent model of colitis
12. Impedance Planimetry for Crohnʼs Disease Anastomotic Stricture Characterization: A Predictor of Treatment Response?
13. Successful liver-directed gene delivery by ERCP-guided hydrodynamic injection (with videos)
14. Use of Biologics for the Treatment of Inflammatory Conditions of the Pouch: A Systematic Review.
15. Extracellular Vesicles in Hepatocellular Carcinoma: Progress and Challenges in the Translation from the Laboratory to Clinic
16. Antibody Kinetics after Three Doses of SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
17. Non-Viral Gene Delivery to Hepatocellular Carcinoma via Intra-Arterial Injection
18. PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease.
19. Supplementary Table 1 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
20. Supplementary Table 3 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
21. Supplementary Figure 2 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
22. Supplementary Figure Legends 1-2 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
23. Supplementary Table 2 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
24. Supplementary Methods section from Identification of Genes Uniquely Involved in Frequent Microsatellite Instability Colon Carcinogenesis by Expression Profiling Combined with Epigenetic Scanning
25. Data from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
26. Supplementary Figure 1 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
27. Supplementary Table 1 from Identification of Genes Uniquely Involved in Frequent Microsatellite Instability Colon Carcinogenesis by Expression Profiling Combined with Epigenetic Scanning
28. Supplementary Table 2 from Identification of Genes Uniquely Involved in Frequent Microsatellite Instability Colon Carcinogenesis by Expression Profiling Combined with Epigenetic Scanning
29. Data from Identification of Genes Uniquely Involved in Frequent Microsatellite Instability Colon Carcinogenesis by Expression Profiling Combined with Epigenetic Scanning
30. Supplementary Table 4 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
31. Use of Biologics for the Treatment of Inflammatory Conditions of the Pouch
32. A nanofiber-hydrogel composite improves tissue repair in a rat model of Crohn’s disease perianal fistulas
33. Autonomous Untethered Microinjectors for Gastrointestinal Delivery of Insulin
34. Biostimulatory Micro‐Fragmented Nanofiber‐Hydrogel Composite Improves Mesenchymal Stem Cell Delivery and Soft Tissue Remodeling
35. Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
36. Extracellular vesicles as novel therapeutics in hepatic failure
37. Exosome miR‐335 as a novel therapeutic strategy in hepatocellular carcinoma
38. Quaternary nanoparticles enable sustained release of bortezomib for hepatocellular carcinoma
39. Adipokine C1q/Tumor necrosis factor-Related Protein 3 (CTRP3) Attenuates Intestinal Inflammation via Histone Deacetylase Sirtuin 1 (SIRT1)/NF-κB Signaling
40. Sa1528: LYOPHILIZED UMBILICAL CORD TISSUE IS EFFECTIVE AS FISTULA PLUG IN A RAT MODEL OF CROHN'S PERIANAL FISTULA
41. Sa1527: A NONOFIBER-HYDROGEL SCAFFOLD EMBEDDED WITH MESENCHYMAL STEM CELLS FOR THE TREATMENT OF CROHN'S PERIANAL FISTULAS IN A RAT MODEL
42. Mo1556: INFLIXIMAB VERSUS ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN’S DISEASE
43. Sa1602: DISEASE OUTCOMES AFTER SEGMENTAL RESECTION OF COLONIC CROHN'S DISEASE: A RETROSPECTIVE MULTICENTER STUDY.
44. Sa1064: IMPACT OF COVID-19 PANDEMIC ON PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A LOCAL REPORT
45. 948: QUATERNARY COMPLEX NANOPARTICLES ENABLE TARGETED, SUSTAINED RELEASE BORTEZOMIB OF HEPATOCELLULAR CARCINOMA
46. Mo1121: ADIPOKINE C1Q/TNF-RELATED PROTEIN 3 (CTRP3) SUPPRESSES COLONIC INFLAMMATION IN MOUSE COLITIS MODELS
47. Tu1658: ENTERAL INSULIN DELIVERED BY ANTONOMOUS MICROINJECTORS
48. A Novel Patient-like Swine Model of Perianal Crohn’s Disease
49. Mo1784 HIGH-RESOLUTION IMPEDANCE PLANIMETRY CHARACTERIZES THE MECHANICAL FEATURES OF CROHN'S DISEASE STRICTURES – IMPLICATIONS FOR PATIENT STRATIFICATION
50. 1239 PAIN IN INFLAMMATORY BOWEL DISEASE: A FUNCTION OF DISEASE ACTIVITY OR CENTRAL SENSITIZATION?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.